Feasibility of Therapy With Hypomethylating Agents in Patients With Renal Insufficiency

BACKGROUND: To our knowledge, the feasibility of therapy with hypomethylating agents (HAs) in patients with renal insufficiency (RI) has not been examined. PATIENTS AND METHODS: We reviewed 41 patients with a diagnosis of acute myeloid leukemia (n = 17), myelodysplastic syndromes (n = 15), and chron...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Batty, G. Nicolas, Kantarjian, Hagop, Issa, Jean-Pierre, Jabbour, Elias, Santos, Fabio P. S., McCue, Deborah, Garcia-Manero, Guillermo, Pierce, Sherry, O’Brien, Susan, Cortés, Jorge E., Ravandi, Farhad
Format: Artigo
Jezik:Inglês
Izdano: 2010
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3726276/
https://ncbi.nlm.nih.gov/pubmed/20511166
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3816/CLML.2010.n.032
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items